DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has ...
DUBLIN--(BUSINESS WIRE)--The "United States Non Invasive Prenatal Testing (NIPT) Market Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecast 2023 ...
The birth of every new life is to be celebrated. During the first trimester of pregnancy, doctors from the department of gynecology and obstetrics may suggest pregnant mothers undertake noninvasive ...
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Noninvasive ...
Ethical and Analytic Challenges With Genomic Sequencing of Relapsed Hematologic Malignancies Following Allogeneic Hematopoietic Stem-Cell Transplantation Noninvasive prenatal testing (NIPT) is a ...
In this interview, NewsMedical speaks with Iris Meng, Foetal Medicine Specialist at the Shanghai First Maternity and Infant Hospital in Shanghai, China, about the applications of non-invasive prenatal ...
SAN CARLOS, Calif., Aug. 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive prenatal testing, announced a joint guideline released yesterday by the American College of ...
Natera says it has begun making good on its priorities for 2021, which include expansions in noninvasive prenatal testing (NIPT), transplant rejection testing, minimal residual disease (MRD) cancer ...
Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and the European leader in non-invasive prenatal testing (NIPT), announces that it has signed an agreement with ...
MELBOURNE, Australia, July 05, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (GENE), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results